The incidences of drug resistant strains are becoming more and more common while many manufacturers have stepped back on the antibiotic development. These two factors have created a situation that has almost sent patients and physicians back to the pre-antibiotic era. Join Maryn McKenna author of “Superbug” as she explores the history and rise of multi-drug resistant MRSA.
What You Will Learn
- Review the rise of multi-drug resistant MRSA and CRE
- Understand the complexities of MDROs in healthcare
- Review the decline in antimicrobial development
- Explore the structure of possible incentives to encourage new drugs
- And much more!
Date: Thursday, February 28, 2013
Time: 2:00-3:00 pm ET
Meet Your Experts
Maryn McKenna is a journalist and author specializing in public health, global health and food policy. She blogs for Wired, is a columnist for Scientific American, and writes for Slate, the Guardian, Nature, SELF, More and other major publications. She is the author of SUPERBUG (2010) and BEATING BACK THE DEVIL (2004), both published by Free Press/Simon & Schuster. She is a Senior Fellow of the Schuster Institute for Investigative Journalism at Brandeis University.
Dr. David Harwell is the Assistant Director for Career Management and Development at ACS. In his job, he works with chemical professionals throughout their careers. He is a chemist by training and a career counselor by profession. Before joining the staff of ACS Dave was a faculty member at the University of Hawaii focusing on silicon nanoparticles and supramolecular structures.
The Fine Print
ACS Webinars™ does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.